ArticleBMC cancer2025
Impact of preoperative abdominal MRI staging on outcomes for stage II-III colon cancer: a propensity score-matched cohort study.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectivePreoperative MRI staging offers a noninvasive approach to assess local tumor invasion and distant metastasis. Attention has been paid to investigating the impact of preoperative abdominal MRI staging on the prognosis of patients with stage II-III colon cancer.
methodsPatients who underwent radical resection for stage II-III colon cancer at Yunnan Cancer Hospital between 2008 and 2017 were retrospectively analyzed and divided into preoperative MRI and non-MRI groups. Propensity score matching (PSM) was applied to balance patient characteristics. Overall survival (OS) and Disease-free survival (DFS) were compared using the Kaplan-Meier method and log-rank test. Additionally, Cox regression was used to evaluate the correlation between preoperative MRI and prognosis, and subgroup analyses further compared the two groups. For multivariable analysis, two models were constructed and compared.
resultsAmong 1086 patients included, 29.28% underwent preoperative abdominal MRI. Patients who received preoperative MRI demonstrated better OS (log-rank p = 0.002), particularly those with stage III colon cancer (p < 0.05). After PSM, the MRI group exhibited significantly better 5-year OS (90.0% vs. 82.0%, P = 0.019) and a lower risk of death (HR, 1.66; 95% CI, 1.07-2.56; P = 0.024). Subgroup analysis revealed that the OS of preoperative MRI was significant in stage III patients. However, no significant difference was observed in DFS between the two groups. Furthermore, compared to the MRI group, the non-MRI group showed a statistically significant increased risk in model 1 (OR = 1.63, 95% CI: 1.08-2.44, P = 0.020) and model 2 (OR = 1.79, 95% CI: 1.17-2.73, P = 0.007) in terms of OS.
conclusionPreoperative abdominal MRI significantly enhances OS in patients with stage II-III colon cancer, especially in those with stage III disease. However, the specific role of MRI in treatment planning, as well as the potential impact of different treatment approaches on outcomes, warrants further investigation into the treatment decision-making processes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.